Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kyprianos Michaelides, Maruthi Prasanna, Raj Badhan, Afzal-Ur-Rahman Mohammed, Adam Walters, M. Keith Howard, Pawan Dulal & Ali Al-Khattawi. (2023) Single administration vaccines: delivery challenges, in vivo performance, and translational considerations. Expert Review of Vaccines 22:1, pages 579-595.
Read now
Read now
Bruna Rodrigues Dias Assis, Isabela Pereira Gomes, Júlia Teixeira de Castro, Graziella Gomes Rivelli, Natália Salazar de Castro, Diana Paola Gomez-Mendoza, Flávia Fonseca Bagno, Natália Satchiko Hojo-Souza, Ana Luiza Chaves Maia, Eduardo Burgarelli Lages, Flávio Guimaraes da Fonseca, Santuza Maria Ribeiro Teixeira, Ana Paula Fernandes, Ricardo Tostes Gazzinelli & Gisele Assis Castro Goulart. (2023) Quality Attributes of Ctvad1, A Nanoemulsified Adjuvant for Phase I Clinical Trial of SpiN COVID-19 Vaccine. Nanomedicine 18:18, pages 1175-1194.
Read now
Read now
Anindita De & Young Tag Ko. (2023) Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out. Expert Opinion on Drug Delivery 20:2, pages 175-187.
Read now
Read now
Daniel A. Abramowicz & Shah Karim. (2021) Risk and Resilience in Supply Chains. Research-Technology Management 64:6, pages 33-40.
Read now
Read now
Articles from other publishers (26)
Amirhossein Moadab, Ghazale Kordi, Mohammad Mahdi Paydar, Ali Divsalar & Mostafa Hajiaghaei-Keshteli. (2023) Designing a sustainable-resilient-responsive supply chain network considering uncertainty in the COVID-19 era. Expert Systems with Applications 227, pages 120334.
Crossref
Crossref
Sina Abbasi, Sasan Zahmatkesh, Awais Bokhari & Mostafa Hajiaghaei-Keshteli. (2023) Designing a vaccine supply chain network considering environmental aspects. Journal of Cleaner Production 417, pages 137935.
Crossref
Crossref
Md.Ashikur Rahman, Riaz Mahamud Chayon, Abdul Aziz, Fatema Tuj Johora Faria, Md. Aminul Islam & Md Rashedur Rahman. (2023) A Comparative Study on Different Approaches of COVID-19 Vaccines. European Journal of Pharmaceutical Research 3:4, pages 1-13.
Crossref
Crossref
Jelle J. Feddema, Kenneth D.S. Fernald, Hans G.C.P. Schikan & Linda H.M. van de Burgwal. (2023) Upscaling vaccine manufacturing capacity - key bottlenecks and lessons learned. Vaccine 41:30, pages 4359-4368.
Crossref
Crossref
Pooja DhimanAmit Kumar. (2023) A Situational Based Reliability Indices Estimation of ULT Freezer using Preventive Maintenance under Fuzzy Environment. International Journal of Mathematical, Engineering and Management Sciences 8:3, pages 477-503.
Crossref
Crossref
Xinyuan Liang. (2023) Research on COVID-19 Vaccine Supply Chain Disruption Recovery Strategy from Resilience Perspective. Academic Journal of Management and Social Sciences 2:3, pages 105-113.
Crossref
Crossref
Subhodeep Mukherjee, Manish Mohan Baral, Venkataiah Chittipaka, Surya Kant Pal & Ramji Nagariya. (2022) Investigating sustainable development for the COVID-19 vaccine supply chain: a structural equation modelling approach. Journal of Humanitarian Logistics and Supply Chain Management 13:2, pages 199-215.
Crossref
Crossref
Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, Joshua A. Imperatore, Caylee L. Cunningham, Caleb J. Frye, Patrick E. Lackey, Mihaela Rita Mihailescu & Jeffrey D. Evanseck. (2022) Structural, Dynamical, and Entropic Differences between SARS-CoV and SARS-CoV-2 s2m Elements Using Molecular Dynamics Simulations. ACS Physical Chemistry Au 3:1, pages 30-43.
Crossref
Crossref
Vivek Chavda, Shailvi Soni, Lalitkumar Vora, Shruti Soni, Avinash Khadela & Jinal Ajabiya. (2022) mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10:12, pages 2150.
Crossref
Crossref
Emily A. Voigt, Alana Gerhardt, Derek Hanson, Madeleine F. Jennewein, Peter Battisti, Sierra Reed, Jasneet Singh, Raodoh Mohamath, Julie Bakken, Samuel Beaver, Christopher Press, Patrick Soon-Shiong, Christopher J. Paddon, Christopher B. Fox & Corey Casper. (2022) A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability. npj Vaccines 7:1.
Crossref
Crossref
Petar Radanliev, David De Roure, Carsten Maple & Uchenna Ani. (2021) Methodology for integrating artificial intelligence in healthcare systems: learning from COVID-19 to prepare for Disease X. AI and Ethics 2:4, pages 623-630.
Crossref
Crossref
Naimur Rahman Chowdhury, Mushaer Ahmed, Priom Mahmud, Sanjoy Kumar Paul & Sharmine Akther Liza. (2022) Modeling a sustainable vaccine supply chain for a healthcare system. Journal of Cleaner Production 370, pages 133423.
Crossref
Crossref
Lin Gan, Yan Chen, Jinlin Tan, Xuezhi Wang & Dingmei Zhang. (2022) Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis. BMC Infectious Diseases 22:1.
Crossref
Crossref
Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang & Xing Zhao. (2022) mRNA vaccines in the prevention and treatment of diseases. MedComm 3:3.
Crossref
Crossref
Zahra Ghaemmaghamian, Reza Zarghami, Gavin Walker, Emmet O’Reilly & Ahmad Ziaee. (2022) Stabilizing vaccines via drying: Quality by design considerations. Advanced Drug Delivery Reviews 187, pages 114313.
Crossref
Crossref
Pravin Kumar, Rajesh Kumar Singh & Azar Shahgholian. (2022) Learnings from COVID-19 for managing humanitarian supply chains: systematic literature review and future research directions. Annals of Operations Research.
Crossref
Crossref
Jill Whitley, Christopher Zwolinski, Christian Denis, Maureen Maughan, Leonie Hayles, David Clarke, Meghan Snare, Hong Liao, Sean Chiou, Tina Marmura, Holly Zoeller, Ben Hudson, John Peart, Monica Johnson, Amelia Karlsson, Yunfei Wang, Cynthia Nagle, Cherell Harris, Daniel Tonkin, Stephanie Fraser, Lieza Capiz, Christina L. Zeno, Yvonne Meli, Diana Martik, Daniel A. Ozaki, Amy Caparoni, Jason E. Dickens, Drew Weissman, Kevin O. Saunders, Barton F. Haynes, Gregory D. Sempowski, Thomas N. Denny & Matthew R. Johnson. (2022) Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials. Translational Research 242, pages 38-55.
Crossref
Crossref
Zoltán Kis, Kyungjae Tak, Dauda Ibrahim, Maria M. Papathanasiou, Benoît Chachuat, Nilay Shah & Cleo Kontoravdi. (2022) Pandemic-response adenoviral vector and RNA vaccine manufacturing. npj Vaccines 7:1.
Crossref
Crossref
Tien-Ching Chang, Bing-Mae Chen, Jer-Yuan Wu, Tian-Lu Cheng & Steve Roffler. (2022) Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice. Biomedicine & Pharmacotherapy 146, pages 112502.
Crossref
Crossref
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Eleni Stamoula, Catherine K. Markopoulou, Anna Karagianni & Kyriakos Kachrimanis. (2021) mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 10:1, pages 50.
Crossref
Crossref
Maureen S Golan, Emerson Mahoney, Benjamin Trump & Igor Linkov. (2021) Resilience and efficiency for the nanotechnology supply chains underpinning COVID-19 vaccine development. Current Opinion in Chemical Engineering 34, pages 100759.
Crossref
Crossref
Tianran Ren, Jun Ren, Ben Matellini, Samuel Tammas-Williams & Wu Ouyang. (2021) The trend of modern cold chain management: Characteristics, challenges and opportunities of vaccine logistics. The trend of modern cold chain management: Characteristics, challenges and opportunities of vaccine logistics.
Benoît Gamain, Arnaud Chêne, Nicola K. Viebig, Nicaise Tuikue Ndam & Morten A. Nielsen. (2021) Progress and Insights Toward an Effective Placental Malaria Vaccine. Frontiers in Immunology 12.
Crossref
Crossref
Maureen S. Golan, Benjamin D. Trump, Jeffrey C. Cegan & Igor Linkov. 2021. COVID-19: Systemic Risk and Resilience. COVID-19: Systemic Risk and Resilience
389
437
.
Vincenzo Lariccia, Simona Magi, Tiziano Serfilippi, Marwa Toujani, Santo Gratteri & Salvatore Amoroso. (2020) Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review. Journal of Clinical Medicine 9:12, pages 4021.
Crossref
Crossref
Luca Tudor Giurgea & Matthew James Memoli. (2020) Navigating the Quagmire: Comparison and Interpretation of COVID-19 Vaccine Phase 1/2 Clinical Trials. Vaccines 8:4, pages 746.
Crossref
Crossref